Liu Yinglong, chief physician, professor and doctoral supervisor, has been engaged in medical treatment, teaching and research of cardiac surgery for nearly 40 years, and has made outstanding contributions to congenital heart disease surgery. Mainly engaged in the clinical work of heart valve and complex congenital heart disease, especially in the clinical and basic research to improve the surgical effect of severe complex congenital heart disease in infants such as pulmonary atresia, complete transposition of great arteries, tricuspid valve depression, tricuspid valve atresia, double outlet of right ventricle and severe pulmonary hypertension. At the same time, we have actively promoted the establishment of a three-level prevention and treatment network system for congenital heart disease for many years. Clinically, there are 3000 outpatient visits and 1 000 operations every year. 10 Many innovative technologies.

In 20 12, the list of "Top 100 Famous Doctors in China" was obtained. Published more than 20 papers/kloc-0, and participated in 6 books. His research on GK and BN prosthetic valves won the first prize 1988 from the Academy of Medical Sciences and the third prize 1986 from the National Science and Technology Progress Award. The hemodynamic research of artificial heart valve won the second prize of Sun Shi Research Fund of the Ministry of Health1988; "Analysis and research on surgical effect and high-risk factors of tetralogy of Fallot in children aged 3 ~ 5 years" won the second prize of scientific and technological progress of the Ministry of Health1998; "Surgical treatment of complex congenital heart disease in severe infants" won the second prize of Beijing Science and Technology Progress Award1998; "Clinical research on improving the curative effect of tetralogy of Fallot and analysis of high-risk factors" won the third prize of National Science and Technology Progress Award1999; "Research on the treatment and application of correcting congenital heart malformation in children through right lateral incision" won the second prize of scientific and technological progress in Beijing in 2000; "Basic and clinical experimental research related to improving the surgical effect of severe complex congenital heart disease in infants" won the second prize of China Medical Science and Technology Progress in 2002 and the second prize of Wu Jieping Medical Research-Zhan Sen Pharmaceutical Research in 2002.